BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 14739160)

  • 1. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction.
    van Rooij E; Doevendans PA; Crijns HJ; Heeneman S; Lips DJ; van Bilsen M; Williams RS; Olson EN; Bassel-Duby R; Rothermel BA; De Windt LJ
    Circ Res; 2004 Feb; 94(3):e18-26. PubMed ID: 14739160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
    Niizeki T; Takeishi Y; Arimoto T; Takahashi H; Shishido T; Koyama Y; Goto K; Walsh RA; Kubota I
    Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1105-12. PubMed ID: 17071729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc.
    Heineke J; Ruetten H; Willenbockel C; Gross SC; Naguib M; Schaefer A; Kempf T; Hilfiker-Kleiner D; Caroni P; Kraft T; Kaiser RA; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1655-60. PubMed ID: 15665106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
    Du XJ; Gao XM; Kiriazis H; Moore XL; Ming Z; Su Y; Finch AM; Hannan RA; Dart AM; Graham RM
    Cardiovasc Res; 2006 Sep; 71(4):735-43. PubMed ID: 16859660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
    Janssens S; Pokreisz P; Schoonjans L; Pellens M; Vermeersch P; Tjwa M; Jans P; Scherrer-Crosbie M; Picard MH; Szelid Z; Gillijns H; Van de Werf F; Collen D; Bloch KD
    Circ Res; 2004 May; 94(9):1256-62. PubMed ID: 15044322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides.
    Tokudome T; Horio T; Kishimoto I; Soeki T; Mori K; Kawano Y; Kohno M; Garbers DL; Nakao K; Kangawa K
    Circulation; 2005 Jun; 111(23):3095-104. PubMed ID: 15939815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doppler echocardiographic assessment and cardiac gene expression analysis of the left ventricle in myocardial infarcted rats.
    Shimizu N; Yoshiyama M; Takeuchi K; Hanatani A; Kim S; Omura T; Iwao H; Yoshikawa J
    Jpn Circ J; 1998 Jun; 62(6):436-42. PubMed ID: 9652320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Shiomi T; Tsutsui H; Matsusaka H; Murakami K; Hayashidani S; Ikeuchi M; Wen J; Kubota T; Utsumi H; Takeshita A
    Circulation; 2004 Feb; 109(4):544-9. PubMed ID: 14744974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
    Trueblood NA; Xie Z; Communal C; Sam F; Ngoy S; Liaw L; Jenkins AW; Wang J; Sawyer DB; Bing OH; Apstein CS; Colucci WS; Singh K
    Circ Res; 2001 May; 88(10):1080-7. PubMed ID: 11375279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.
    Li Q; Xu Y; Li X; Guo Y; Liu G
    Toxicol Lett; 2012 Jun; 211(2):91-7. PubMed ID: 22465603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
    Rothermel BA; McKinsey TA; Vega RB; Nicol RL; Mammen P; Yang J; Antos CL; Shelton JM; Bassel-Duby R; Olson EN; Williams RS
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3328-33. PubMed ID: 11248078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of apolipoprotein B attenuates pathologic cardiac remodeling and hypertrophy in response to catecholamines and after myocardial infarction in mice.
    Råmunddal T; Lindbom M; Täng MS; Shao Y; Borén J; Omerovic E
    Scand J Clin Lab Invest; 2012 May; 72(3):230-6. PubMed ID: 22283829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sex on ventricular remodeling after myocardial infarction in mice.
    Wu JC; Nasseri BA; Bloch KD; Picard MH; Scherrer-Crosbie M
    J Am Soc Echocardiogr; 2003 Nov; 16(11):1158-62. PubMed ID: 14608287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction.
    Gidh-Jain M; Huang B; Jain P; Gick G; El-Sherif N
    J Mol Cell Cardiol; 1998 Mar; 30(3):627-37. PubMed ID: 9515038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats.
    Lapointe N; Parker TG; Tsoporis JN; Nguyen QT; Marcotte F; Adam A; Lou I; Rouleau JL
    Can J Cardiol; 2005 Mar; 21(3):291-7. PubMed ID: 15776120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biglycan is required for adaptive remodeling after myocardial infarction.
    Westermann D; Mersmann J; Melchior A; Freudenberger T; Petrik C; Schaefer L; Lüllmann-Rauch R; Lettau O; Jacoby C; Schrader J; Brand-Herrmann SM; Young MF; Schultheiss HP; Levkau B; Baba HA; Unger T; Zacharowski K; Tschöpe C; Fischer JW
    Circulation; 2008 Mar; 117(10):1269-76. PubMed ID: 18299507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice.
    Riad A; Jäger S; Sobirey M; Escher F; Yaulema-Riss A; Westermann D; Karatas A; Heimesaat MM; Bereswill S; Dragun D; Pauschinger M; Schultheiss HP; Tschöpe C
    J Immunol; 2008 May; 180(10):6954-61. PubMed ID: 18453617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.